tiprankstipranks
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress ReleasesCyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
1M ago
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
PremiumPress Releases
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
1M ago
Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
PremiumThe Fly
Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
1M ago
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
PremiumPress ReleasesCyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
3M ago
Cyclacel Pharmaceuticals files to sell 411,969 shares of common stock for holder
PremiumThe Fly
Cyclacel Pharmaceuticals files to sell 411,969 shares of common stock for holder
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
PremiumPress ReleasesCyclacel Pharmaceuticals to Present at Biotech Showcase 2024
4M ago
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
4M ago
Cyclacel Pharmaceuticals prices registered direct offering at $3.315 per share
PremiumThe Fly
Cyclacel Pharmaceuticals prices registered direct offering at $3.315 per share
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100